RARITAN, N.J., March 27, 2018 /PRNewswire/ -- Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics,
"Ortho has a long legacy of leadership in diagnostics," said Robert Yates, Ortho's chief operating officer. "Our recent product launches, including numerous assays for clinical labs and the ORTHO VISION® Platform of immunohematology analyzers, underscore that commitment.
Over the last two years, Ortho has been broadly recognized for customer service, innovation, quality, safety, sustainability and brand renovation with several awards.
About the AwardLE FONTI® SRL is a research institute and a global independent publishing house headquartered in Milan with more than 10 years of experience in the publishing field, with major shareholders from Europe and Asia. LeFonti® is one of the fastest growing magazines worldwide concerning Excellence in Innovation & Leadership. It is a quarterly magazine published by LE FONTI ®. It is also the first of its kind, according to Alexa - Amazon, for international ranking and for its related number of readers.
About Ortho Clinical DiagnosticsOrtho Clinical Diagnostics is a global leader of in vitro diagnostics serving the clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks and labs in more than 125 countries and territories, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.
View original content:http://www.prnewswire.com/news-releases/lefonti-awards-recognize-ortho-clinical-diagnostics-with-global-award-for-excellence-in-innovation-and-leadership-300620115.html
SOURCE Ortho Clinical Diagnostics
Subscribe to our Free Newsletters!
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...View All